Pages that link to "Q69770561"

The following pages link to Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study (Q69770561):

Displaying 21 items.

• Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma (Q28345115) (← links)
• CCK2 receptor expression transforms non-tumorigenic human NCM356 colonic epithelial cells into tumor forming cells (Q33560737) (← links)
• Diagnosis of pernicious anemia and the risk of pancreatic cancer (Q33586606) (← links)
• Effect of chronic endogenous hypergastrinaemia on pancreatic growth and carcinogenesis in the hamster (Q33774309) (← links)
• Serum vitamin B12 and folate status among patients with chemotherapy treatment for advanced colorectal cancer (Q33781843) (← links)
• Pancreatic hypertrophy with acinar cell nodules after longterm fundectomy in the rat (Q34376891) (← links)
• Use of Proton Pump Inhibitor and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies. (Q34463547) (← links)
• Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression (Q36190380) (← links)
• Cancer Risk After Pernicious Anemia in the US Elderly Population (Q36304871) (← links)
• Session 6: Is Hypergastrinaemia Dangerous to Man? (Q36495932) (← links)
• The consequences of hypergastrinemia (Q36987482) (← links)
• Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis (Q40595580) (← links)
• Pathophysiological effects of long-term acid suppression in man. (Q40595597) (← links)
• Gut hormones, growth and malignancy (Q40621757) (← links)
• Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders (Q40729290) (← links)
• Gastrin and colorectal cancer. Evidence against an association (Q41114303) (← links)
• Gastrin, gastrin receptors and colorectal carcinoma (Q41998447) (← links)
• Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome (Q51034919) (← links)
• Omeprazole-induced hypergastrinemia does not influence growth of colon carcinoma (Q68078836) (← links)
• Risk of fractures in patients with pernicious anemia (Q68178972) (← links)
• Drug-induced hypergastrinemia: Absence of trophic effects on colonic carcinoma in rats (Q72114692) (← links)